Medicare Pay Cut Goes into Effect on Monday

WASHINGTON (MedPage Today) — A 21% cut in Medicare reimbursement will go into effect March 1, after the Senate failed to pass a bill to stop the cuts.

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Geoffrey I. Shapiro of Dana-Farber Cancer Institute, presented preclinical and clinical data on STA-9090, a potent second-generation Hsp90 inhibitor, at IASLC (International Association for the Study of Lung Cancer) 10th Annual [...]

Teva Pharmaceutical announces clinical study results of Copaxone in RRMS patients

Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.

Light Sciences Oncology Meets A Major Milestone In Aptocine Development With Target Enrollment In Phase 3 MCRC Trial

Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocine™ (talaporfin sodium) for treatment of solid tumors. LSO’s global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites…

Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer

Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy…

Ferring Pharmaceuticals And Gene Security Network Partner To Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology

Ferring Pharmaceuticals and Gene Security Network (GSN) announced that they have signed an agreement to conduct a clinical trial of GSN’s advanced preimplantation genetic diagnosis (PGD) technology, Parental Support™. The 11-center U.S…

History And Future Of Laser Technology Highlighted At 2010 AAAS Annual Meeting

As part of LaserFest, the year-long celebration of the 50th anniversary of the first working laser, the Optical Society (OSA) and the American Physical Society (APS) sponsored a special day-long seminar on the birth, growth and future developments in laser science and technology at the 2010 American Association for the Advancement of Science (AAAS) annual [...]

Efficient Identification Of Drug Candidates - A Hot Road To New Drugs

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate…

Canada’s pharmaceutical products industry stands out strong during recession

Canada’s pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada’s Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at [...]

Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares

Midlothian Laboratories, a division of Hi-Tech Pharmacal Co., Inc., as part of its continuing humanitarian relief efforts, recently donated more than $3 million worth of essential vitamins and nutritional supplements to AmeriCares for people in the developing world living in extreme poverty and suffering from chronic malnutrition.